Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Viruses|July 30, 2025
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral TherapyJenna M Hasson, Mary Grace Katusiime, Adam A Capoferri, et al.The Lancet. HIV|September 16, 2024
Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort studySam Nightingale, Anna J Dreyer, Kevin G F Thomas, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeksClaire M Keene, Tali Cassidy, Ying Zhao, et al.The Pediatric Infectious Disease Journal|July 30, 2024
HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South AfricaKim Anderson, Gert van Zyl, Nei-Yuan Hsiao, et al.The Lancet. HIV|June 21, 2025
Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxisGert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, et al.AIDS Research and Human Retroviruses|April 3, 2019
Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence CohortElizabeth Gonese, Peter H Kilmarx, Cari van Schalkwyk, et al.African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|May 2, 2022
SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitalsLiezl Smit, Andrew Redfern, Sadia Murray, et al.Southern African Journal of HIV Medicine|March 24, 2018
Adult antiretroviral therapy guidelines 2017Graeme Meintjes, Michelle A Moorhouse, Sergio Carmona, et al.Journal of Global Antimicrobial Resistance|August 28, 2024
Virological impact of HIV drug-resistance testing in children, adolescents, and adults failing first-line ART in TanzaniaShimba Henerico, Eric Lyimo, Abel N Makubi, et al.Plos One|September 3, 2011
HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically highChrista Kasang, Samuel Kalluvya, Charles Majinge, et al.Pageof 8